Sertraline for social phobia: A double-blind, placebo-controlled crossover study

American Journal of Psychiatry

Volumn 152, Issue 9, 1995, Pages 1368-1371

  Katzelnick, David J ^a,b   Kobak, Kenneth A ^a   Greist, John H ^a   Jefferson, James W ^a   Mantle, Julia M ^a   Serlin, Ronald C ^a  

^a Res and Educ ^*

^b Dean Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SOCIAL ADAPTATION; TREATMENT OUTCOME;

EID: 0029094582     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.152.9.1368     Document Type: Article

References (39)

1. Kessler RC, McGonagle KA, Zhoa SZ, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51:8-19
2. Liebowitz MR: Social phobia, in Modern Problems of Pharmacopsychiatry, vol 22: Anxiety. Edited by Klein DF. New York, Karger, 1987
3. Gorman JM, Gorman LK: Drug treatment of social phobia. J Affect Disord 1987; 13:183-192
4. Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer AJ, Gorman JM, Papp L, Davies S, Gulley R, Klein DR: Phenelzine vs atenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 1992; 49:290-300
5. Lydiard RB, Laraia MT, Howell EF, Ballenger JC: Alptazolam in the treatment of social phobia. J Clin Psychiatry 1988; 49:17-19
6. Reich J, Yates W: A pilot study of treatment of social phobia with alprazolam. Am J Psychiatry 1988; 145:590-594
7. Davidson JRT, Potts NLS, Richichi EA, Krishnan R, Ford SM, Smith RD, Wilson W: Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993; 13:423-428
8. Sternbach H: Fluoxetine treatment of social phobia (letter). J Clin Psychopharmacol 1990; 10:230
9. McGlynn TJ, Metcalf HL: Diagnosis and Treatment of Anxiety Disorders: A Physician's Handbook. Washington, DC, American Psychiatric Press, 1989, pp 93-96
10. Liebowitz MR, Gorman JM, Fyer AJ, Klein DF: Social phobia: review of a neglected anxiety disorder. Arch Gen Psychiatry 1985; 42:729-736
11. Beaumont G: Conclusion. Br J Psychiatry 1993; 163(suppl 2): 40-42
12. Wernicke JF, Dunlop SR, Dornseif BE, Zerbe RL: Fixed-dose fluoxetine therapy for depression. Psychopharmacol Bull 1987; 23:164-168
13. Dunner DL, Dunbar GC: Optimal dose regimen for paroxetine. J Clin Psychiatry 1992; 53(Feb suppl):21-26
14. Schneier FR, Chin SJ, Hollander E, Liebowitz MR: Fluoxetine in social phobia (letter). J Clin Psychopharmacol 1992; 12:62-64
15. Black B, Uhde TW, Tancer ME: Fluoxetine for the treatment of social phobia (letter). J Clin Psychopharmacol 1992; 12:293-295
16. Van Ameringen M, Mancini C, Streiner DL: Fluoxetine efficacy in social phobia. J Clin Psychiatry 1993; 54:27-32
17. Van Ameringen M, Mancini C, Streiner DL, Jeeves P: Sertraline treatment in social phobia: a pilot study (abstract). Neuropsychopharmacology 1994; 10(suppl 3, part 2):196S
18. Czepowicz VD, Johnson MR, Emmanuel NP, Lydiard RB, Ballenger JC: Sertraline in social phobia, in New Research Program and Abstracts, 147th Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1994
19. Martins DA, Pigott TA, Bernstein S, Doyle BB, Smolka VM: Sertraline pharmacotherapy in patients with social phobia. Ibid
20. Munjack D: Zoloft (sertraline) in the treatment of social phobia (abstract). Neuropsychopharmacology 1994; 10(suppl 3, part 2): 196S
21. van Vliet IM, den Boer JA, Westenberg HG: Psychopharmacological treatment of social phobia: a double blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 1994; 115:128-134
22. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
23. Davidson JRT, Potts NLS, Richichi EA, Ford SM, Krishnan KRR, Smith RD, Wilson W: The Brief Social Phobia Scale. J Clin Psychiatry 1991; 52:48-51
24. Marks IM, Mathews AM: Brief standard self-rating for phobic patients. Behav Res Ther 1982; 17:263-267
25. Sheehan DV: The Anxiety Disease. New York, Bantam, 1983, p 138
26. Stewart AL, Hays R, Ware JE: The MOS Short-Form General Health Survey: reliability and validity in a patient population. Med Care 1988; 26:724-735
27. Liebowitz MR, Gorman JM, Fyer AJ, Campeas R, Levin AP, Sandberg D, Hollander E, Papp L, Goetz D: Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol. J Clin Psychiatry 1988; 49:242-257
28. Hills M, Armitage P: The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8:7-20
29. Cochran WG: A comparison of percentages in matched samples. Biometrika 1950; 37:256-266
30. Kobak KA, Reynolds WM, Greist JH: Computerized and clinician assessment of depression and anxiety: respondent evaluation and satisfaction. J Pers Assess 1994; 63:173-180
31. Cleophas TJM: Crossover studies: a modified analysis with more power. Clin Pharmacol Ther 1993; 53:515-520
32. Cody RL, Slack MK: Crossover design in pharmacy research. Ann Pharmacother 1992; 26:327-333
33. Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL: Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145: 1521-1525
34. Pato MT, Murphy DL, DeVane CL: Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol 1991; 11:224-225
35. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrien R: Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1994; 161: 353-360
36. Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K, Mendels J, Sikes C: Double-blind parallel comparison of three doses of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52:289-295
37. Rosenfeld R, Dar R, Anderson D, Kobak KA, Greist JH: A computer administered version of the Yale-Brown Obsessive Compulsive Scale. Psychol Assessment 1992; 4:329-332
38. Kobak KA, Reynolds WM, Rosenfeld R, Greist JH: Development and validation of a computer-administered version of the Hamilton Depression Rating Scale. Psychol Assessment 1990; 2:56-63
39. Kobak KA, Reynolds WM, Greist JH: Development and validation of a computer-administered version of the Hamilton Anxiety Scale. Psychol Assessment 1993; 5:487-492